Citation Impact
Citing Papers
Localization of the Gene for Sclerosteosis to the van Buchem Disease–Gene Region on Chromosome 17q12–q21
1999
Magnetic Iron Oxide Nanoparticles: Synthesis and Surface Functionalization Strategies
2008 Standout
Acute Epiploic Appendagitis and Its Mimics
2005 Standout
Iridium‐Complex‐Functionalized Fe3O4/SiO2 Core/Shell Nanoparticles: A Facile Three‐in‐One System in Magnetic Resonance Imaging, Luminescence Imaging, and Photodynamic Therapy
2008
Improved tissue characterization of focal liver lesions with ferumoxide-enhanced T1 and T2-weighted MR imaging
2000
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
2004 Standout
Peritoneal Sclerosis: One or Two Nosological Entities?
2000
Evaluation of retroperitoneal and pelvic lymph node metastases with MRI and MR lymphangiography
2003
Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C
2005 Standout
Bone Dysplasia Sclerosteosis Results from Loss of the SOST Gene Product, a Novel Cystine Knot–Containing Protein
2001 StandoutNobel
A 52‐kb deletion in the SOST‐MEOX1 intergenic region on 17q12‐q21 is associated with van Buchem disease in the Dutch population
2002 StandoutNobel
Mesostructured Silica for Optical Functionality, Nanomachines, and Drug Delivery
2008 StandoutNobel
Antithrombotic Therapy for VTE Disease
2016 Standout
Contrast agents in magnetic resonance imaging of the liver: Present and future
1998
Nanoparticles in cancer therapy and diagnosis
2002 Standout
Hepatic MRI with SPIO: detection and characterization of focal liver lesions
1998
CT Findings in Sclerosing Mesenteritis (Panniculitis): Spectrum of Disease
2003
Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis
1998
Superparamagnetic Agents in Magnetic Resonance Imaging: Physicochemical Characteristics and Clinical Applications A Review
1998
ACR Appropriateness Criteria® on Renal Failure
2014
Diagnosis of DVT
2012
Cytotoxicity of Nanoparticles
2007 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy
2010 Standout
Nephrogenic Systemic Fibrosis
2006 Standout
Diagnostic efficacy and safety of MRI of the liver with superparamagnetic iron oxide particles (SH U 555 A)
2001
Morphologic Changes in the Peritoneal Membrane of Patients with Renal Disease
2002 Standout
Liver positive enhancement after injection of superparamagnetic nanoparticles: Respective role of circulating and uptaken particles
1997
Executive Summary
2012 Standout
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
2009 Standout
3D bioprinting of tissues and organs
2014 Standout
Magnetic nanoparticles in MR imaging and drug delivery
2008 Standout
Sclerostin: how human mutations have helped reveal a new target for the treatment of osteoporosis
2013 StandoutNobel
Efficacy of non-invasive elastometry on staging of hepatic fibrosis
2004
Contrast Agents for MR Imaging of the Liver
2001
Recent advances in iron oxide nanocrystal technology for medical imaging☆
2006
Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia
2000 Standout
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology
2013 Standout
Gadolinium – a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?
2006 Standout
Lysosomal degradation of the carboxydextran shell of coated superparamagnetic iron oxide nanoparticles and the fate of professional phagocytes
2010
Chronic Kidney Disease
2016 Standout
Towards clinically translatable in vivo nanodiagnostics
2017
IODINATED CONTRAST AGENTS IN NEURORADIOLOGY
1994
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Clearance Properties of Nano-Sized Particles and Molecules as Imaging Agents: Considerations and Caveats
2008 Standout
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
2002 Standout
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
Abdominal Computed Tomography Predicts Progression in Patients With Rai Stage 0 Chronic Lymphocytic Leukemia
2007
Multifunctional Inorganic Nanoparticles for Imaging, Targeting, and Drug Delivery
2008 Standout
Starch-Coated Superparamagnetic Nanoparticles as MR Contrast Agents
2003
Size-Controlled Synthesis of Magnetite Nanoparticles
2002 Standout
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Monodisperse MFe2O4 (M = Fe, Co, Mn) Nanoparticles
2003 Standout
Applications of magnetic nanoparticles in biomedicine
2003 Standout
Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia
1999 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Synthesis, properties, and applications of magnetic iron oxide nanoparticles
2008 Standout
Core/Shell Nanoparticles: Classes, Properties, Synthesis Mechanisms, Characterization, and Applications
2011 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Iodinated contrast agents in neuroradiology
1998
Magnetic nanoparticle design for medical diagnosis and therapy
2004 Standout
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis
1981 Standout
Inorganic Nanoparticles for MRI Contrast Agents
2009 Standout
Works of J Grellet being referenced
[New cases of familial generalized cortical hyperostosis with dominant transmission (Worth's type) (author's transl)].
1976
Effects of Intravenous Infusion of Urographic Contrast Agents on Glomerular Filtration Rate, Serum Concentration and Urinary Excretion of Uric Acid in Subjects with Normal Renal Function
1987
GD-DOTA: Evaluation of its renal tolerance in patients with chronic renal failure
1992
Liver metastases: safety and efficacy of detection with superparamagnetic iron oxide in MR imaging.
1994
Demonstration of efficacy of combining corticosteroids and colchicine in two patients with idiopathic sclerosing mesenteritis
1996
[Prospective study of echography versus phlebography in the detection of sural venous thrombosis].
1992
Correlation between lymphographic grouping and anatomic and clinical stages in chronic lymphoid leukemia
1979